Biotime Inc - Net Worth and Insider Trading
Biotime Inc Net Worth
The estimated net worth of Biotime Inc is at least $803,474 dollars as of 2024-05-04. Biotime Inc is the Previous 10% Owner of OncoCyte Corp and owns about 302,058 shares of OncoCyte Corp (OCX) stock worth over $803,474. Details can be seen in Biotime Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biotime Inc has not made any transactions after 2020-01-02 and currently still holds the listed stock(s).
Transaction Summary of Biotime Inc
Biotime Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotime Inc owns 2 companies in total, including OncoCyte Corp (OCX) , and Asterias Biotherapeutics Inc (AST) .
Click here to see the complete history of Biotime Inc’s form 4 insider trades.
Insider Ownership Summary of Biotime Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCX | OncoCyte Corp | 2020-01-02 | 10 percent owner |
| AST | Asterias Biotherapeutics Inc | 2016-02-29 | 10 percent owner |
Biotime Inc Latest Holdings Summary
Biotime Inc currently owns a total of 1 stock. Biotime Inc owns 302,058 shares of OncoCyte Corp (OCX) as of January 2, 2020, with a value of $803,474.
Latest Holdings of Biotime Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCX | OncoCyte Corp | 2020-01-02 | 302,058 | 2.66 | 803,474 |
Holding Weightings of Biotime Inc
Biotime Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotime Inc has made a total of 3 transactions in OncoCyte Corp (OCX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in OncoCyte Corp is the sale of 119,155 shares on January 2, 2020, which brought Biotime Inc around $5 Million.
Insider Trading History of Biotime Inc
- 1
Biotime Inc Trading Performance
Biotime Inc Ownership Network
Biotime Inc Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
Biotime Inc is the 10 percent owner of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Biotime Inc made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 29,247,638 shares made by Broadwood Partners Lp , a net purchase of 283,898 shares made by Andrew Arno , and a net purchase of 55,000 shares made by Alfred D Kingsley .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 2,457,288 shares, with a net purchase of 2,457,288 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,850,820 shares were bought by its insiders, resulting in a net purchase of 3,850,820 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
Biotime Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Biotime Inc. You might contact Biotime Inc via mailing address: 2173 Salk Avenue, Suite 200, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
